The BBC News reported recently that a woman died after medical
staff stored important clinical notes on sticky notepaper and
paper towels. In August 2005, 78 year old Patricia Prowse was
admitted to hospital for a minor operation. Eight days later Mrs
Prowse suffered from a stroke and was not given essential
anti-clotting medication.
The coroners verdict was logged as death by natural causes, but
it was mentioned that errors had contributed to the womans
death.
An
inquest revealed that Mrs Prowse had been taking warfarin prior
to going into hospital, and was supposed to have been given
several injections of Clexane after the operation, but only
received one jab, due to confusion and missing medical notes.
Mrs Prowse's granddaughter Kelly Day said that her family are
disgusted, and commented, "People should be able to go into
hospital for a minor operation and come out alive rather than
dying like this".
To view the full article, follow the link below:
|
Dosing Protocol Following a Procedure |
|

Several customers have commented that it takes a long time to
re-establish INR control once a patient has stopped warfarin
for a procedure. Dr. Roger Rehr and Mary Camilli-Muhr from the
Cardiology Associates of West Reading in the USA are Dawn AC
users and use the following regimen successfully for bringing
patients back into therapeutic range after a procedure:
"On the evening of the procedure, the patient takes 1.5 times
their "usual" warfarin dose for that day based on their regimen
prior to holding warfarin for the procedure. They then continue
on their prior regimen thereafter, and an INR is checked in 1
week.
Use of this protocol requires a specific review for each patient
to confirm that it is appropriate for that particular patient,
and of course there are well-recognized patient groups that are
NOT appropriately managed by this protocol. These groups include
but are not necessarily limited to patients with recent
thromboembolism, prosthetic cardiac valve in place less than 6
months, Bjork-Shiley valve, or the presence of three risk
factors for thromboembolism [as defined by the AHA/ACC to
include atrial fibrillation, LV dysfunction, previous
thromboembolism, hypercoagulable condition, mechanical
prosthesis], or the presence of a mechanical mitral prosthesis
plus one risk factor."
This may be helpful guidance for some users who want to develop
a protocol for post-procedure care. If you have any comments on
the above or wish to provide any feedback or ideas, then please
email us at syd@4s-dawn.com.